Malignant Pleural Mesothelioma, Advanced Clinical Trials
2 recruiting trials for Malignant Pleural Mesothelioma, Advanced. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT06031636
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
The purpose of this study is to evaluate the efficacy and safety of Oncolytic Adenovirus(H101) combined with PD-1 inhibitor in patients with advanced malignant pleural...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 151 location
RECRUITINGPhase 1NCT06756035
CT-95 in Advanced Cancers Associated With Mesothelin Expression
This is a Phase 1a/1b open-label, dose escalation study to evaluate the safety and efficacy of CT-95 (study drug), a humanized T cell engaging bispecific antibody targeting...
Sponsor: Context Therapeutics Inc.Enrolling: 708 locations